Biofrontera confirms financing need
30 juin 2020 08h30 HE
|
Biofrontera AG
Leverkusen, Germany, June 30, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today confirmed the...
Biofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial results
09 avr. 2020 12h30 HE
|
Biofrontera AG
Leverkusen, Germany, April 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck
03 févr. 2020 05h45 HE
|
Biofrontera AG
Leverkusen, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019
10 oct. 2019 05h15 HE
|
Biofrontera AG
Leverkusen, Germany, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
Biofrontera to present at the Baader Investment Conference
17 sept. 2019 09h45 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced that Prof....
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
11 juil. 2019 05h23 HE
|
Biofrontera AG
Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares
21 juin 2019 03h30 HE
|
Biofrontera AG
The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbHThe Management Board intends to help Maruho Deutschland GmbH to successfully complete its...
Biofrontera Reports First Quarter 2019 Financial Results
29 mai 2019 03h11 HE
|
Biofrontera AG
Leverkusen, Germany, May 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...